Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague–Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles

Gastrointestinal toxicity is a frequently observed adverse event during cancer treatment with traditional chemotherapeutics. Currently, traditional chemotherapeutics are often combined with targeted biologic agents. These biologics, however, possess a distinct toxicity profile, and they may also exa...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Richard A. Forsgård, Vannina G Marrachelli, Jere Lindén, Rafael Frias, Maria Carmen Collado, Riitta Korpela, Daniel Monleon, Thomas Spillmann, Pia Österlund
Format:	Artigo
Język:	Inglês
Wydane:	Elsevier 2019-08-01
Seria:	Translational Oncology
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S1936523319300439
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!